Joule Unlimited

Joule Unlimited developed a solar-to-fuel platform called Helioculture, using engineered photosynthetic microorganisms (cyanobacteria) in a patented bioreactor system to convert carbon dioxide directly into hydrocarbon fuels like ethanol and diesel. The process eliminated the need for biomass feedstock or land use associated with traditional biofuels (per company disclosures, 2011).

Flagship Pioneering, the venture creation firm behind Moderna, incubated Joule Unlimited. Later investors included KSR, a London-based asset manager, and several family offices. The company also secured a $25M grant from the US Department of Energy in 2011 (per DOE announcement).

Public records indicate that by 2018, Joule Unlimited had pivoted or ceased core operations, with no recent operational activity reported. Its patent portfolio likely remains, but the firm is not known to be currently producing fuels or chemicals (per TechCrunch, 2018).

In 2013, Joule Unlimited announced a partnership with Audi to produce a synthetic diesel fuel called 'e-diesel' using its Helioculture process. The partnership was meant to pilot a commercial fuel production facility in the US, though no subsequent commercial scale-up was reported (per Audi media release, 2013).

Yes, the company operated a pilot facility in Leander, Texas, designed to demonstrate its bioprocess at a small commercial scale. The plant was part of a $50M+ buildout, but it is unclear if it ever reached continuous production before the company's pivot (per company press releases, 2012).

Unlike cellulosic or algae-based biofuel companies, Joule did not use biomass or require fermentation of sugars. Instead, its cyanobacteria directly secreted fuel molecules into the liquid medium, enabling a continuous, single-reactor process that the company claimed could be ten-fold more efficient per acre than corn ethanol (per Joule's white papers, 2011).

No public record of an IP sale or license exists. The US Patent and Trademark Office shows assignments to 'Joule Unlimited Technologies, Inc.' for patents related to cyanobacteria strains and photobioreactor systems. Any successor ownership is unknown.